TrialThe New England journal of medicine2017
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5,101 papers cite itlatest 60 shown
this papertrialcites it